PubMed:23347858 JSONTXT

{"project":"Allie","denotations":[{"id":"SS1_23347858_2_0","span":{"begin":298,"end":332},"obj":"expanded"},{"id":"SS2_23347858_2_0","span":{"begin":334,"end":337},"obj":"abbr"},{"id":"SS1_23347858_2_1","span":{"begin":343,"end":399},"obj":"expanded"},{"id":"SS2_23347858_2_1","span":{"begin":401,"end":407},"obj":"abbr"},{"id":"SS1_23347858_2_2","span":{"begin":439,"end":463},"obj":"expanded"},{"id":"SS2_23347858_2_2","span":{"begin":465,"end":468},"obj":"abbr"}],"relations":[{"id":"AE1_23347858_2_0","pred":"abbreviatedTo","subj":"SS1_23347858_2_0","obj":"SS2_23347858_2_0"},{"id":"AE1_23347858_2_1","pred":"abbreviatedTo","subj":"SS1_23347858_2_1","obj":"SS2_23347858_2_1"},{"id":"AE1_23347858_2_2","pred":"abbreviatedTo","subj":"SS1_23347858_2_2","obj":"SS2_23347858_2_2"}],"text":"Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 10-year follow-up of a randomized trial.\nOBJECTIVES: The aim of this prospective, randomized trial was to assess the 10-year long-term safety and effectiveness of percutaneous coronary intervention (PCI) and minimally invasive direct coronary artery bypass surgery (MIDCAB) for the treatment of proximal left anterior descending (LAD) lesions.\nBACKGROUND: Long-term follow-up data comparing PCI and MIDCAB surgery for isolated proximal LAD lesions are sparse.\nMETHODS: Patients with significant isolated proximal LAD stenoses were randomized either to PCI with bare-metal stents (n = 110) or MIDCAB (n = 110). At 10 years, data were obtained with respect to the primary endpoint (death, myocardial infarction, target vessel revascularization). Angina was assessed by the Canadian Cardiovascular Society classification.\nRESULTS: Follow-up was conducted for 212 patients at a median time of 10.3 years. There were no significant differences in the binary primary composite endpoint (47% vs. 36%; p = 0.12) and hard endpoints (death and infarction) between PCI and MIDCAB. However, a higher target vessel revascularization rate in the PCI group (34% vs. 11%; p \u003c 0.01) was observed. Clinical symptoms improved significantly from baseline and were similar between both treatment groups.\nCONCLUSIONS: At 10-year follow-up, PCI and MIDCAB in isolated proximal LAD lesions yielded similar long-term outcomes regarding the primary composite clinical endpoint. Target vessel revascularization was more frequent in the PCI group."}

{"project":"yaoziqian_800_3","denotations":[{"id":"T11","span":{"begin":93,"end":133},"obj":"DP"},{"id":"T12","span":{"begin":430,"end":477},"obj":"DP"},{"id":"T13","span":{"begin":553,"end":582},"obj":"DP"},{"id":"T14","span":{"begin":1471,"end":1500},"obj":"DP"},{"id":"T15","span":{"begin":630,"end":660},"obj":"DP"}],"text":"Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 10-year follow-up of a randomized trial.\nOBJECTIVES: The aim of this prospective, randomized trial was to assess the 10-year long-term safety and effectiveness of percutaneous coronary intervention (PCI) and minimally invasive direct coronary artery bypass surgery (MIDCAB) for the treatment of proximal left anterior descending (LAD) lesions.\nBACKGROUND: Long-term follow-up data comparing PCI and MIDCAB surgery for isolated proximal LAD lesions are sparse.\nMETHODS: Patients with significant isolated proximal LAD stenoses were randomized either to PCI with bare-metal stents (n = 110) or MIDCAB (n = 110). At 10 years, data were obtained with respect to the primary endpoint (death, myocardial infarction, target vessel revascularization). Angina was assessed by the Canadian Cardiovascular Society classification.\nRESULTS: Follow-up was conducted for 212 patients at a median time of 10.3 years. There were no significant differences in the binary primary composite endpoint (47% vs. 36%; p = 0.12) and hard endpoints (death and infarction) between PCI and MIDCAB. However, a higher target vessel revascularization rate in the PCI group (34% vs. 11%; p \u003c 0.01) was observed. Clinical symptoms improved significantly from baseline and were similar between both treatment groups.\nCONCLUSIONS: At 10-year follow-up, PCI and MIDCAB in isolated proximal LAD lesions yielded similar long-term outcomes regarding the primary composite clinical endpoint. Target vessel revascularization was more frequent in the PCI group."}

{"project":"Zierdiyeerkenaili_800_3","denotations":[{"id":"T1","span":{"begin":430,"end":477},"obj":"DP"},{"id":"T3","span":{"begin":93,"end":133},"obj":"DP"},{"id":"T4","span":{"begin":1471,"end":1500},"obj":"DP"},{"id":"T5","span":{"begin":553,"end":582},"obj":"DP"},{"id":"T6","span":{"begin":630,"end":660},"obj":"DP"}],"text":"Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 10-year follow-up of a randomized trial.\nOBJECTIVES: The aim of this prospective, randomized trial was to assess the 10-year long-term safety and effectiveness of percutaneous coronary intervention (PCI) and minimally invasive direct coronary artery bypass surgery (MIDCAB) for the treatment of proximal left anterior descending (LAD) lesions.\nBACKGROUND: Long-term follow-up data comparing PCI and MIDCAB surgery for isolated proximal LAD lesions are sparse.\nMETHODS: Patients with significant isolated proximal LAD stenoses were randomized either to PCI with bare-metal stents (n = 110) or MIDCAB (n = 110). At 10 years, data were obtained with respect to the primary endpoint (death, myocardial infarction, target vessel revascularization). Angina was assessed by the Canadian Cardiovascular Society classification.\nRESULTS: Follow-up was conducted for 212 patients at a median time of 10.3 years. There were no significant differences in the binary primary composite endpoint (47% vs. 36%; p = 0.12) and hard endpoints (death and infarction) between PCI and MIDCAB. However, a higher target vessel revascularization rate in the PCI group (34% vs. 11%; p \u003c 0.01) was observed. Clinical symptoms improved significantly from baseline and were similar between both treatment groups.\nCONCLUSIONS: At 10-year follow-up, PCI and MIDCAB in isolated proximal LAD lesions yielded similar long-term outcomes regarding the primary composite clinical endpoint. Target vessel revascularization was more frequent in the PCI group."}